![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/14 | (2006.01) |
C07D 401/14 | (2013.01) |
(11) | Number of the document | 3969445 |
(13) | Kind of document | T |
(96) | European patent application number | 20726960.6 |
Date of filing the European patent application | 2020-05-15 | |
(97) | Date of publication of the European application | 2022-03-23 |
(45) | Date of publication and mention of the grant of the patent | 2024-11-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2020/054629 |
Date | 2020-05-15 |
(87) | Number | WO 2020/230100 |
Date | 2020-11-19 |
(30) | Number | Date | Country code |
201962848869 P | 2019-05-16 | US | |
201962929995 P | 2019-11-04 | US |
(72) |
BLANK, Jarred , CH
KOECHER, Christian , CH
PACHINGER, Werner Heinz , CH
PAREDES, Galatea , CH
SPAETI, Markus , CH
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | PROCESS FOR THE PREPARATION OF N-[4-(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-5-YL)PYRIDINE-3-CARBOXAMIDE |
PROCESS FOR THE PREPARATION OF N-[4-(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-5-YL)PYRIDINE-3-CARBOXAMIDE |